Kristian M. Vollan

Oslo, 0407, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.

Journal: Nature communications

Published: January 30, 2019

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.

Journal: Nature communications

Published: December 19, 2018

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

Journal: Genome medicine

Published: August 14, 2018

Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity.

Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity.

Journal: Oncotarget

Published: March 27, 2017

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.

Journal: Breast cancer research : BCR

Published: July 15, 2016

Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors.

Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors.

Journal: Endocrine-related cancer

Published: September 22, 2015

Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.

Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.

Journal: Breast cancer research : BCR

Published: November 05, 2014

Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53.

Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53.

Journal: Molecular cancer research : MCR

Published: October 30, 2014

Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer.

Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer.

Journal: Genome medicine

Published: September 08, 2014

Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.

Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.

Journal: BMC cancer

Published: July 15, 2014

A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer.

A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer.

Journal: Molecular oncology

Published: June 24, 2014

TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance.

TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 08, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026